{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:09:29Z","timestamp":1788592169240,"version":"build-2803163510"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The human central nervous system (CNS) has a limited capacity for regeneration and repair,\nas many other organs do. Partly as a result, neurological diseases are the leading cause of medical burden globally. Most neurological disorders cannot be cured, and primary treatments focus on managing\ntheir symptoms and slowing down their progression. Cell therapy for neurological disorders offers\nseveral therapeutic potentials and provides hope for many patients. Here we provide a general overview of cell therapy in neurological disorders such as Parkinson\u2019s disease (PD), Alzheimer\u2019s disease\n(AD), amyotrophic lateral sclerosis (ALS), Wilson\u2019s disease (WD), stroke and traumatic brain injury\n(TBI), involving many forms of stem cells, including embryonic stem cells and induced pluripotent\nstem cells. We also address the current concerns and perspectives for the future. Most studies for cell\ntherapy in neurological diseases are in the pre-clinical stage, and there is still a great need for further\nresearch to translate neural replacement and regenerative therapies into clinical settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x22666240509092903","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T09:15:34Z","timestamp":1719566134000},"page":"2272-2283","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward"],"prefix":"10.2174","volume":"22","author":[{"given":"Xiao-Yan","family":"Song","sequence":"first","affiliation":[{"name":"Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai,\nChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-xiu","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University,\nSchool of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Atta-ur-Rahman","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and\nBiological Sciences, University of Karachi, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Iqbal","family":"Choudhary","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and\nBiological Sciences, University of Karachi, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University,\nSchool of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"Feigin V.L.","year":"2020","unstructured":"Feigin V.L.; Vos T.; Nichols E.; Owolabi M.O.; Carroll W.M.; Dichgans M.; Deuschl G.; Parmar P.; Brainin M.; Murray C.; The global burden of neurological disorders: translating evidence into policy. Lancet Neurol  2020,19(3),255-265","journal-title":"Lancet Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neuroscience.2015.01.038","volume":"290","author":"Zhu J.","year":"2015","unstructured":"Zhu J.; Liu Q.; Jiang Y.; Wu L.; Xu G.; Liu X.; Enhanced angiogenesis promoted by human umbilical mesenchymal stem cell transplantation in stroked mouse is Notch1 signaling associated. Neuroscience  2015,290,288-299","journal-title":"Neuroscience"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/sctm.19-0327","volume":"9","author":"Losurdo M.","year":"2020","unstructured":"Losurdo M.; Pedrazzoli M.; D\u2019Agostino C.; Elia C.A.; Massenzio F.; Lonati E.; Mauri M.; Rizzi L.; Molteni L.; Bresciani E.; Dander E.; D\u2019Amico G.; Bulbarelli A.; Torsello A.; Matteoli M.; Buffelli M.; Coco S.; Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer\u2019s disease. Stem Cells Transl Med  2020,9(9),1068-1084","journal-title":"Stem Cells Transl Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/ijms22010365","volume":"22","author":"Giraldo E.","year":"2020","unstructured":"Giraldo E.; Palmero-Canton D.; Martinez-Rojas B.; Sanchez-Martin M.M.; Moreno-Manzano V.; Optogenetic modulation of neural progenitor cells improves neuroregenerative potential. Int J Mol Sci  2020,22(1),365","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.clpt.6100337","volume":"82","author":"Goldman S.A.","year":"2007","unstructured":"Goldman S.A.; Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Clin Pharmacol Ther  2007,82(4),453-460","journal-title":"Clin Pharmacol Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1570159X14666151120123025","volume":"14","author":"Dong J.","year":"2016","unstructured":"Dong J.; Cui Y.; Li S.; Le W.; Current pharmaceutical treatments and alternative therapies of Parkinson\u2019s disease. Curr Neuropharmacol  2016,14(4),339-355","journal-title":"Curr Neuropharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.571147","volume":"204","author":"Perlow M.J.","year":"1979","unstructured":"Perlow M.J.; Freed W.J.; Hoffer B.J.; Seiger A.; Olson L.; Wyatt R.J.; Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science  1979,204(4393),643-647","journal-title":"Science"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(88)90950-6","volume":"332","author":"Lindvall O.","year":"1988","unstructured":"Lindvall O.; Gustavii B.; \u00c5stedt B.; Lindholm T.; Rehncrona S.; Brundin P.; Widner H.; Bj\u00f6rklund A.; Leenders K.L.; Frackowiak R.; Rothwell J.C.; Marsden C.D.; Johnels B.; Steg G.; Freedman R.; Hopper B.J.; Seiger \u00c5.; Str\u00f6mberg I.; Olson M.B.L.; Olson L.; Fetal dopamine-rich mesencephalic grafts in Parkinson\u2019s disease. Lancet  1988,332(8626-8627),1483-1484","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJM198801073180115","volume":"318","author":"Madrazo I.","year":"1988","unstructured":"Madrazo I.; Le\u00f3n V.; Torres C.; Aguilera M.C.; Varela G.; Alvarez F.; Fraga A.; Drucker-Col\u00edn R.; Ostrosky F.; Skurovich M.; Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson\u2019s disease. N Engl J Med  1988,318(1),51","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"Freed C.R.","year":"2001","unstructured":"Freed C.R.; Greene P.E.; Breeze R.E.; Tsai W.Y.; DuMouchel W.; Kao R.; Dillon S.; Winfield H.; Culver S.; Trojanowski J.Q.; Eidelberg D.; Fahn S.; Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N Engl J Med  2001,344(10),710-719","journal-title":"N Engl J Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JPD-140432","volume":"4","author":"Moore S.F.","year":"2014","unstructured":"Moore S.F.; Guzman N.V.; Mason S.L.; Williams-Gray C.H.; Barker R.A.; Which patients with Parkinson\u2019s disease participate in clinical trials? One centre\u2019s experiences with a new cell based therapy trial (TRANSEURO). J Parkinsons Dis  2014,4(4),671-676","journal-title":"J Parkinsons Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.pbr.2016.11.011","volume":"230","author":"Kirkeby A.","year":"2017","unstructured":"Kirkeby A.; Parmar M.; Barker R.A.;  Strategies for bringing stem cell-derived dopamine neurons to the clinic Prog Brain Res,  2017,230,165-190","journal-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic Prog Brain Res,"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","volume":"25","author":"Barker R.A.","year":"2019","unstructured":"Barker R.A.; Designing stem-cell-based dopamine cell replacement trials for Parkinson\u2019s disease. Nat Med  2019,25(7),1045-1053","journal-title":"Nat Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/618631","volume":"2015","author":"Xiao J.J.","year":"2015","unstructured":"Xiao J.J.; Yin M.; Wang Z.J.; Wang X.P.; Transplanted neural stem cells: Playing a neuroprotective role by ceruloplasmin in the substantia nigra of PD model rats? Oxid Med Cell Longev  2015,2015,1-9","journal-title":"Oxid Med Cell Longev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"dev156117","DOI":"10.1242\/dev.156117","volume":"145","author":"Parmar M.","year":"2018","unstructured":"Parmar M.; Towards stem cell based therapies for Parkinson\u2019s disease. Development  2018,145(1),dev156117","journal-title":"Development"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"34478","DOI":"10.1038\/srep34478","volume":"6","author":"Garitaonandia I.","year":"2016","unstructured":"Garitaonandia I.; Gonzalez R.; Christiansen-Weber T.; Abramihina T.; Poustovoitov M.; Noskov A.; Sherman G.; Semechkin A.; Snyder E.; Kern R.; Neural stem cell tumorigenicity and biodistribution assessment for phase I clinical trial in Parkinson\u2019s disease. Sci Rep  2016,6(1),34478","journal-title":"Sci Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","volume":"11","author":"Wang Y.K.","year":"2018","unstructured":"Wang Y.K.; Zhu W.W.; Wu M.H.; Wu Y.H.; Liu Z.X.; Liang L.M.; Sheng C.; Hao J.; Wang L.; Li W.; Zhou Q.; Hu B.Y.; Human clinical-grade parthenogenetic ESC-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson\u2019s disease. Stem Cell Reports  2018,11(1),171-182","journal-title":"Stem Cell Reports"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"Piao J.","year":"2021","unstructured":"Piao J.; Zabierowski S.; Dubose B.N.; Hill E.J.; Navare M.; Claros N.; Rosen S.; Ramnarine K.; Horn C.; Fredrickson C.; Wong K.; Safford B.; Kriks S.; El Maarouf A.; Rutishauser U.; Henchcliffe C.; Wang Y.; Riviere I.; Mann S.; Bermudez V.; Irion S.; Studer L.; Tomishima M.; Tabar V.; Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell  2021,28(2),217-229.e7","journal-title":"Cell Stem Cell"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1396735","volume":"2022","author":"Li M.","year":"2022","unstructured":"Li M.; Wang Z.; Zheng T.; Huang T.; Liu B.; Han D.; Liu S.; Liu B.; Li M.; Si W.; Zhang Y.A.; Niu Y.; Chen Z.; Characterization of human-induced neural stem cells and derivatives following transplantation into the central nervous system of a nonhuman primate and rats. Stem Cells Int  2022,2022,1-17","journal-title":"Stem Cells Int"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1089\/scd.2018.0107","volume":"27","author":"Loring J.F.","year":"2018","unstructured":"Loring J.F.; Autologous induced pluripotent stem cell-derived neurons to treat Parkinson\u2019s disease. Stem Cells Dev  2018,27(14),958-959","journal-title":"Stem Cells Dev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41582-021-00465-0","volume":"17","author":"Rivetti di Val Cervo P.","year":"2021","unstructured":"Rivetti di Val Cervo P.; Besusso D.; Conforti P.; Cattaneo E.; hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. Nat Rev Neurol  2021,17(6),381-392","journal-title":"Nat Rev Neurol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"Schweitzer J.S.","year":"2020","unstructured":"Schweitzer J.S.; Song B.; Herrington T.M.; Park T.Y.; Lee N.; Ko S.; Jeon J.; Cha Y.; Kim K.; Li Q.; Henchcliffe C.; Kaplitt M.; Neff C.; Rapalino O.; Seo H.; Lee I.H.; Kim J.; Kim T.; Petsko G.A.; Ritz J.; Cohen B.M.; Kong S.W.; Leblanc P.; Carter B.S.; Kim K.S.; Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med  2020,382(20),1926-1932","journal-title":"N Engl J Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","volume":"13","author":"Takahashi J.","year":"2020","unstructured":"Takahashi J.; iPS cell-based therapy for Parkinson\u2019s disease: A Kyoto trial. Regen Ther  2020,13,18-22","journal-title":"Regen Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2174\/1570159X18666200429011823","volume":"18","author":"Ghosh S.","year":"2020","unstructured":"Ghosh S.; Durgvanshi S.; Agarwal S.; Raghunath M.; Sinha J.K.; Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer\u2019s disease. Curr Neuropharmacol  2020,18(9),883-903","journal-title":"Curr Neuropharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41420-021-00471-7","volume":"7","author":"Garcia-Contreras M.","year":"2021","unstructured":"Garcia-Contreras M.; Thakor A.S.; Human adipose tissue-derived mesenchymal stem cells and their extracellular vesicles modulate lipopolysaccharide activated human microglia. Cell Death Discov  2021,7(1),98","journal-title":"Cell Death Discov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.diff.2009.06.005","volume":"78","author":"Moghadam F.H.","year":"2009","unstructured":"Moghadam F.H.; Alaie H.; Karbalaie K.; Tanhaei S.; Nasr Esfahani M.H.; Baharvand H.; Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. Differentiation  2009,78(2-3),59-68","journal-title":"Differentiation"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jcyt.2018.03.036","volume":"20","author":"Hoveizi E.","year":"2018","unstructured":"Hoveizi E.; Mohammadi T.; Moazedi A.A.; Zamani N.; Eskandary A.; Transplanted neural-like cells improve memory and Alzheimer-like pathology in a rat model. Cytotherapy  2018,20(7),964-973","journal-title":"Cytotherapy"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1474-4422(15)00382-8","volume":"15","author":"Wray S.","year":"2016","unstructured":"Wray S.; Fox N.C.; Stem cell therapy for Alzheimer\u2019s disease: hope or hype? Lancet Neurol  2016,15(2),133-135","journal-title":"Lancet Neurol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.stemcr.2019.10.012","volume":"13","author":"Zhang T.","year":"2019","unstructured":"Zhang T.; Ke W.; Zhou X.; Qian Y.; Feng S.; Wang R.; Cui G.; Tao R.; Guo W.; Duan Y.; Zhang X.; Cao X.; Shu Y.; Yue C.; Jing N.; Human neural stem cells reinforce hippocampal synaptic network and rescue cognitive deficits in a mouse model of Alzheimer\u2019s disease. Stem Cell Reports  2019,13(6),1022-1037","journal-title":"Stem Cell Reports"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1007\/s12035-020-01907-4","volume":"57","author":"Comella-Bolla A.","year":"2020","unstructured":"Comella-Bolla A.; Orlandi J.G.; Miguez A.; Straccia M.; Garc\u00eda-Bravo M.; Bombau G.; Galofr\u00e9 M.; Sanders P.; Carrere J.; Segovia J.C.; Blasi J.; Allen N.D.; Alberch J.; Soriano J.; Canals J.M.; Human pluripotent stem cell-derived neurons are functionally mature in vitro and integrate into the mouse striatum following transplantation. Mol Neurobiol  2020,57(6),2766-2798","journal-title":"Mol Neurobiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-020-0622-x","volume":"27","author":"Hayashi Y.","year":"2020","unstructured":"Hayashi Y.; Lin H.T.; Lee C.C.; Tsai K.J.; Effects of neural stem cell transplantation in Alzheimer\u2019s disease models. J Biomed Sci  2020,27(1),29","journal-title":"J Biomed Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2017.02.006","volume":"106","author":"Marsh S.E.","year":"2017","unstructured":"Marsh S.E.; Blurton-Jones M.; Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. Neurochem Int  2017,106,94-100","journal-title":"Neurochem Int"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.12659\/MSM.894567","volume":"21","author":"Chen Y.","year":"2015","unstructured":"Chen Y.; Pan C.; Xuan A.; Xu L.; Bao G.; Liu F.; Fang J.; Long D.; Treatment efficacy of NGF nanoparticles combining neural stem cell transplantation on Alzheimer\u2019s disease model rats. Med Sci Monit  2015,21,3608-3615","journal-title":"Med Sci Monit"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mri.2018.08.005","volume":"54","author":"Zhang F.","year":"2018","unstructured":"Zhang F.; Chen S.Q.; Tong M.M.; Wang P.J.; Teng G.J.; 7.0 tesla high resolution MRI study on intracerebral migration of magnet-labeled neural stem cells in a mouse model of Alzheimer\u2019s disease. Magn Reson Imaging  2018,54,58-62","journal-title":"Magn Reson Imaging"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-021-00791-x","volume":"13","author":"Apodaca L.A.","year":"2021","unstructured":"Apodaca L.A.; Baddour A.A.D.; Garcia C.; Alikhani L.; Giedzinski E.; Ru N.; Agrawal A.; Acharya M.M.; Baulch J.E.; Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer\u2019s disease. Alzheimers Res Ther  2021,13(1),57","journal-title":"Alzheimers Res Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbr.2016.12.021","volume":"320","author":"Cui Y.","year":"2017","unstructured":"Cui Y.; Ma S.; Zhang C.; Cao W.; Liu M.; Li D.; Lv P.; Xing Q.; Qu R.; Yao N.; Yang B.; Guan F.; Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer\u2019s disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis. Behav Brain Res  2017,320,291-301","journal-title":"Behav Brain Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"101726","DOI":"10.1016\/j.scr.2020.101726","volume":"43","author":"Lee J.","year":"2020","unstructured":"Lee J.; Chang W.S.; Shin J.; Seo Y.; Kong C.; Song B.W.; Na Y.C.; Kim B.S.; Chang J.W.; Non-invasively enhanced intracranial transplantation of mesenchymal stem cells using focused ultrasound mediated by overexpression of cell-adhesion molecules. Stem Cell Res (Amst)  2020,43,101726","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jconrel.2020.02.035","volume":"321","author":"Hour F.Q.","year":"2020","unstructured":"Hour F.Q.; Moghadam A.J.; Shakeri-Zadeh A.; Bakhtiyari M.; Shabani R.; Mehdizadeh M.; Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton\u2019s jelly in Alzheimer\u2019s rat models. J Control Release  2020,321,430-441","journal-title":"J Control Release"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1021\/acs.nanolett.2c03682","volume":"23","author":"Jung M.","year":"2023","unstructured":"Jung M.; Kim H.; Hwang J.W.; Choi Y.; Kang M.; Kim C.; Hong J.; Lee N.K.; Moon S.; Chang J.W.; Choi S.; Oh S.; Jang H.; Na D.L.; Kim B.S.; Iron oxide nanoparticle-incorporated mesenchymal stem cells for Alzheimer\u2019s disease treatment. Nano Lett  2023,23(2),476-490","journal-title":"Nano Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","volume":"13","author":"Kim H.J.","year":"2021","unstructured":"Kim H.J.; Cho K.R.; Jang H.; Lee N.K.; Jung Y.H.; Kim J.P.; Lee J.I.; Chang J.W.; Park S.; Kim S.T.; Moon S.W.; Seo S.W.; Choi S.J.; Na D.L.; Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase I clinical trial. Alzheimers Res Ther  2021,13(1),154","journal-title":"Alzheimers Res Ther"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","volume":"93","author":"Oskarsson B.","year":"2018","unstructured":"Oskarsson B.; Gendron T.F.; Staff N.P.; Amyotrophic lateral sclerosis: An update for 2018. Mayo Clin Proc  2018,93(11),1617-1628","journal-title":"Mayo Clin Proc"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14712598.2018.1503248","volume":"18","author":"Mazzini L.","year":"2018","unstructured":"Mazzini L.; Ferrari D.; Andjus P.R.; Buzanska L.; Cantello R.; De Marchi F.; Gelati M.; Giniatullin R.; Glover J.C.; Grilli M.; Kozlova E.N.; Maioli M.; Mitre\u010di\u0107 D.; Pivoriunas A.; Sanchez-Pernaute R.; Sarnowska A.; Vescovi A.L.; Neurology B.C.A.W.; Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther  2018,18(8),865-881","journal-title":"Expert Opin Biol Ther"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","volume":"93","author":"Berry J.D.","year":"2019","unstructured":"Berry J.D.; Cudkowicz M.E.; Windebank A.J.; Staff N.P.; Owegi M.; Nicholson K.; McKenna-Yasek D.; Levy Y.S.; Abramov N.; Kaspi H.; Mehra M.; Aricha R.; Gothelf Y.; Brown R.H.; NurOwn, phase 2, randomized, clinical trial in patients with ALS. Neurology  2019,93(24),e2294-e2305","journal-title":"Neurology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.3390\/ijms21249593","volume":"21","author":"Forostyak S.","year":"2020","unstructured":"Forostyak S.; Forostyak O.; Kwok J.C.F.; Romanyuk N.; Rehorova M.; Kriska J.; Dayanithi G.; Raha-Chowdhury R.; Jendelova P.; Anderova M.; Fawcett J.W.; Sykova E.; Transplantation of neural precursors derived from induced pluripotent cells preserve perineuronal nets and stimulate neural plasticity in ALS rats. Int J Mol Sci  2020,21(24),9593","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/cne.23578","volume":"522","author":"Sareen D.","year":"2014","unstructured":"Sareen D.; Gowing G.; Sahabian A.; Staggenborg K.; Paradis R.; Avalos P.; Latter J.; Ornelas L.; Garcia L.; Svendsen C.N.; Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol  2014,522(12),2707-2728","journal-title":"J Comp Neurol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-62703-348-0_3","volume":"997","author":"Malik N.","year":"2013","unstructured":"Malik N.; Rao M.S.; A review of the methods for human iPSC derivation. Methods Mol Biol  2013,997,23-33","journal-title":"Methods Mol Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11626-019-00412-w","volume":"56","author":"Hamada A.","year":"2020","unstructured":"Hamada A.; Akagi E.; Yamasaki S.; Nakatao H.; Obayashi F.; Ohtaka M.; Nishimura K.; Nakanishi M.; Toratani S.; Okamoto T.; Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions. In Vitro Cell Dev Biol Anim  2020,56(1),85-95","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1007\/s00415-022-11185-w","volume":"269","author":"Lunetta C.","year":"2022","unstructured":"Lunetta C.; Lizio A.; Cabona C.; Gerardi F.; Sansone V.A.; Corbo M.; Scial\u00f2 C.; Angelucci E.; Gualandi F.; Marenco P.; Grillo G.; Cairoli R.; Cesana C.; Saccardi R.; Melazzini M.G.; Mancardi G.; Caponnetto C.; A phase I\/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis. J Neurol  2022,269(10),5337-5346","journal-title":"J Neurol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1371\/journal.pone.0000689","volume":"2","author":"Suzuki M.","year":"2007","unstructured":"Suzuki M.; McHugh J.; Tork C.; Shelley B.; Klein S.M.; Aebischer P.; Svendsen C.N.; GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One  2007,2(8),e689","journal-title":"PLoS One"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41419-019-1582-5","volume":"10","author":"Zalfa C.","year":"2019","unstructured":"Zalfa C.; Rota Nodari L.; Vacchi E.; Gelati M.; Profico D.; Boido M.; Binda E.; De Filippis L.; Copetti M.; Garlatti V.; Daniele P.; Rosati J.; De Luca A.; Pinos F.; Cajola L.; Visioli A.; Mazzini L.; Vercelli A.; Svelto M.; Vescovi A.L.; Ferrari D.; Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats. Cell Death Dis  2019,10(5),345","journal-title":"Cell Death Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.201206-1072OC","volume":"187","author":"Nichols N.L.","year":"2013","unstructured":"Nichols N.L.; Gowing G.; Satriotomo I.; Nashold L.J.; Dale E.A.; Suzuki M.; Avalos P.; Mulcrone P.L.; McHugh J.; Svendsen C.N.; Mitchell G.S.; Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. Am J Respir Crit Care Med  2013,187(5),535-542","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/stem.2825","volume":"36","author":"Thomsen G.M.","year":"2018","unstructured":"Thomsen G.M.; Avalos P.; Ma A.A.; Alkaslasi M.; Cho N.; Wyss L.; Vit J.P.; Godoy M.; Suezaki P.; Shelest O.; Bankiewicz K.S.; Svendsen C.N.; Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cells  2018,36(7),1122-1131","journal-title":"Stem Cells"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"s138","DOI":"10.47391\/JPMA.AKUS-22","volume":"73","author":"Khalid M.U.","year":"2023","unstructured":"Khalid M.U.; Masroor T.; The promise of stem cells in amyotrophic lateral sclerosis: A review of clinical trials. J Pak Med Assoc  2023,73(2),s138-s142","journal-title":"J Pak Med Assoc"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12967-023-03903-3","volume":"21","author":"Gotkine M.","year":"2023","unstructured":"Gotkine M.; Caraco Y.; Lerner Y.; Blotnick S.; Wanounou M.; Slutsky S.G.; Chebath J.; Kuperstein G.; Estrin E.; Ben-Hur T.; Hasson A.; Molakandov K.; Sonnenfeld T.; Stark Y.; Revel A.; Revel M.; Izrael M.; Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx\u00ae) in ALS patients: phase I\/IIa clinical trial results. J Transl Med  2023,21(1),122","journal-title":"J Transl Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-6506-9_11","volume":"1506","author":"Jaber F.L.","year":"2017","unstructured":"Jaber F.L.; Sharma Y.; Gupta S.; Demonstrating potential of cell therapy for Wilson\u2019s disease with the long-evans cinnamon rat model. Methods Mol Biol  2017,1506,161-178","journal-title":"Methods Mol Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/hep.26753","volume":"59","author":"Itoh T.","year":"2014","unstructured":"Itoh T.; Miyajima A.; Liver regeneration by stem\/progenitor cells. Hepatology  2014,59(4),1617-1626","journal-title":"Hepatology"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Cao Y.","year":"2020","unstructured":"Cao Y.; Ji C.; Lu L.; Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Ann Transl Med  2020,8(8),562","journal-title":"Ann Transl Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-019-0107-z","volume":"39","author":"Tsuchiya A.","year":"2019","unstructured":"Tsuchiya A.; Takeuchi S.; Watanabe T.; Yoshida T.; Nojiri S.; Ogawa M.; Terai S.; Mesenchymal stem cell therapies for liver cirrhosis: MSCs as \u201cconducting cells\u201d for improvement of liver fibrosis and regeneration. Inflamm Regen  2019,39(1),18","journal-title":"Inflamm Regen"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbrc.2010.03.158","volume":"395","author":"Sauer V.","year":"2010","unstructured":"Sauer V.; Siaj R.; Todorov T.; Zibert A.; Schmidt H.H.J.; Overexpressed ATP7B protects mesenchymal stem cells from toxic copper. Biochem Biophys Res Commun  2010,395(3),307-311","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.4238\/gmr16019352","volume":"16","author":"Zhang D.","year":"2017","unstructured":"Zhang D.; A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration. Genet Mol Res  2017,16(1)","journal-title":"Genet Mol Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41598-018-38275-y","volume":"9","author":"Fujiyoshi J.","year":"2019","unstructured":"Fujiyoshi J.; Yamaza H.; Sonoda S.; Yuniartha R.; Ihara K.; Nonaka K.; Taguchi T.; Ohga S.; Yamaza T.; Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson\u2019s disease. Sci Rep  2019,9(1),1535","journal-title":"Sci Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"102050","DOI":"10.1016\/j.scr.2020.102050","volume":"49","author":"Wang S.H.","year":"2020","unstructured":"Wang S.H.; Wang X.P.; Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson\u2019s disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene. Stem Cell Res (Amst)  2020,49,102050","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jhep.2015.11.017","volume":"64","author":"Roy-Chowdhury J.","year":"2016","unstructured":"Roy-Chowdhury J.; Schilsky M.L.; Gene therapy of Wilson disease: A \u201cgolden\u201d opportunity using rAAV on the 50th anniversary of the discovery of the virus. J Hepatol  2016,64(2),265-267","journal-title":"J Hepatol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/humc.2018.219","volume":"30","author":"Greig J.A.","year":"2019","unstructured":"Greig J.A.; Nordin J.M.L.; Smith M.K.; Ashley S.N.; Draper C.; Zhu Y.; Bell P.; Buza E.L.; Wilson J.M.; a gene therapy approach to improve copper metabolism and prevent liver damage in a mouse model of Wilson disease. Hum Gene Ther Clin Dev  2019,30(1),29-39","journal-title":"Hum Gene Ther Clin Dev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e0239411","DOI":"10.1371\/journal.pone.0239411","volume":"15","author":"P\u00f6hler M.","year":"2020","unstructured":"P\u00f6hler M.; Guttmann S.; Nadzemova O.; Lenders M.; Brand E.; Zibert A.; Schmidt H.H.; Sandfort V.; CRISPR\/Cas9-mediated correction of mutated copper transporter ATP7B. PLoS One  2020,15(9),e0239411","journal-title":"PLoS One"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/hep.32484","volume":"76","author":"Cai H.","year":"2022","unstructured":"Cai H.; Cheng X.; Wang X.P.; ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson\u2019s disease. Hepatology  2022,76(4),1046-1057","journal-title":"Hepatology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/revneuro-2022-0102","volume":"34","author":"Zolfaghari Baghbadorani P.","year":"2023","unstructured":"Zolfaghari Baghbadorani P.; Rayati Damavandi A.; Moradi S.; Ahmadi M.; Bemani P.; Aria H.; Mottedayyen H.; Rayati Damavandi A.; Eskandari N.; Fathi F.; Current advances in stem cell therapy in the treatment of multiple sclerosis. Rev Neurosci  2023,34(6),613-633","journal-title":"Rev Neurosci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40263-017-0429-9","volume":"31","author":"Sarkar P.","year":"2017","unstructured":"Sarkar P.; Rice C.M.; Scolding N.J.; Cell therapy for multiple sclerosis. CNS Drugs  2017,31(6),453-469","journal-title":"CNS Drugs"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nature03889","volume":"436","author":"Pluchino S.","year":"2005","unstructured":"Pluchino S.; Zanotti L.; Rossi B.; Brambilla E.; Ottoboni L.; Salani G.; Martinello M.; Cattalini A.; Bergami A.; Furlan R.; Comi G.; Constantin G.; Martino G.; Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature  2005,436(7048),266-271","journal-title":"Nature"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41591-022-02097-3","volume":"29","author":"Genchi A.","year":"2023","unstructured":"Genchi A.; Brambilla E.; Sangalli F.; Radaelli M.; Bacigaluppi M.; Furlan R.; Andolfo A.; Drago D.; Magagnotti C.; Scotti G.M.; Greco R.; Vezzulli P.; Ottoboni L.; Bonopane M.; Capilupo D.; Ruffini F.; Belotti D.; Cabiati B.; Cesana S.; Matera G.; Leocani L.; Martinelli V.; Moiola L.; Vago L.; Panina-Bordignon P.; Falini A.; Ciceri F.; Uglietti A.; Sormani M.P.; Comi G.; Battaglia M.A.; Rocca M.A.; Storelli L.; Pagani E.; Gaipa G.; Martino G.; Neural stem cell transplantation in patients with progressive multiple sclerosis: An open-label, phase 1 study. Nat Med  2023,29(1),75-85","journal-title":"Nat Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"944","DOI":"10.12659\/AJCR.899745","volume":"17","author":"Shroff G.","year":"2016","unstructured":"Shroff G.; Transplantation of human embryonic stem cells in patients with multiple sclerosis and lyme disease. Am J Case Rep  2016,17,944-949","journal-title":"Am J Case Rep"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/5584_2018_247","volume":"1084","author":"Genc B.","year":"2018","unstructured":"Genc B.; Bozan H.R.; Genc S.; Genc K.; Stem cell therapy for multiple sclerosis. Adv Exp Med Biol  2018,1084,145-174","journal-title":"Adv Exp Med Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2018.18743","volume":"321","author":"Burt R.K.","year":"2019","unstructured":"Burt R.K.; Balabanov R.; Burman J.; Sharrack B.; Snowden J.A.; Oliveira M.C.; Fagius J.; Rose J.; Nelson F.; Barreira A.A.; Carlson K.; Han X.; Moraes D.; Morgan A.; Quigley K.; Yaung K.; Buckley R.; Alldredge C.; Clendenan A.; Calvario M.A.; Henry J.; Jovanovic B.; Helenowski I.B.; Effect of nonmyeloablative hematopoietic stem cell transplantation vs. continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis. JAMA  2019,321(2),165-174","journal-title":"JAMA"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"Petrou P.","year":"2020","unstructured":"Petrou P.; Kassis I.; Levin N.; Paul F.; Backner Y.; Benoliel T.; Oertel F.C.; Scheel M.; Hallimi M.; Yaghmour N.; Hur T.B.; Ginzberg A.; Levy Y.; Abramsky O.; Karussis D.; Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain  2020,143(12),3574-3588","journal-title":"Brain"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1570159X18666200114160844","volume":"18","author":"Dhir N.","year":"2020","unstructured":"Dhir N.; Medhi B.; Prakash A.; Goyal M.K.; Modi M.; Mohindra S.; Pre-clinical to clinical translational failures and current status of clinical trials in stroke therapy: A brief review. Curr Neuropharmacol  2020,18(7),596-612","journal-title":"Curr Neuropharmacol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0306-4522(92)90306-M","volume":"51","author":"Grabowski M.","year":"1992","unstructured":"Grabowski M.; Christofferson R.H.; Brundin P.; Johansson B.B.; Vascularization of fetal neocortical grafts implanted in brain infarcts in spontaneously hypertensive rats. Neuroscience  1992,51(3),673-682","journal-title":"Neuroscience"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0014-4886(92)90159-N","volume":"116","author":"Grabowski M.","year":"1992","unstructured":"Grabowski M.; Brundin P.; Johansson B.B.; Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: Ingrowth of afferent fibers from the host brain. Exp Neurol  1992,116(2),105-121","journal-title":"Exp Neurol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0361-9230(94)90072-8","volume":"33","author":"Aihara N.","year":"1994","unstructured":"Aihara N.; Mizukawa K.; Koide K.; Mabe H.; Nishino H.; Striatal grafts in infarct striatopallidum increase GABA release, reorganize GABAA receptor and improve water-maze learning in the rat. Brain Res Bull  1994,33(5),483-488","journal-title":"Brain Res Bull"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","volume":"103","author":"Kondziolka D.","year":"2005","unstructured":"Kondziolka D.; Steinberg G.K.; Wechsler L.; Meltzer C.C.; Elder E.; Gebel J.; DeCesare S.; Jovin T.; Zafonte R.; Lebowitz J.; Flickinger J.C.; Tong D.; Marks M.P.; Jamieson C.; Luu D.; Bell-Stephens T.; Teraoka J.; Neurotransplantation for patients with subcortical motor stroke: a Phase 2 randomized trial. J Neurosurg  2005,103(1),38-45","journal-title":"J Neurosurg"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000086518","volume":"20","author":"Savitz S.I.","year":"2005","unstructured":"Savitz S.I.; Dinsmore J.; Wu J.; Henderson G.V.; Stieg P.; Caplan L.R.; Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis  2005,20(2),101-107","journal-title":"Cerebrovasc Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1729146615","DOI":"10.1016\/j.brainres.2019.146615","author":"Willis C.M.","year":"2020","unstructured":"Willis C.M.; Nicaise A.M.; Peruzzotti-Jametti L.; Pluchino S.; The neural stem cell secretome and its role in brain repair. Brain Res  2020,1729146615","journal-title":"Brain Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"Hess D.C.","year":"2017","unstructured":"Hess D.C.; Wechsler L.R.; Clark W.M.; Savitz S.I.; Ford G.A.; Chiu D.; Yavagal D.R.; Uchino K.; Liebeskind D.S.; Auchus A.P.; Sen S.; Sila C.A.; Vest J.D.; Mays R.W.; Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol  2017,16(5),360-368","journal-title":"Lancet Neurol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/STROKEAHA.110.601914","volume":"42","author":"Savitz S.I.","year":"2011","unstructured":"Savitz S.I.; Chopp M.; Deans R.; Carmichael S.T.; Phinney D.; Wechsler L.; Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke  2011,42(3),825-829","journal-title":"Stroke"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/STROKEAHA.113.003379","volume":"45","author":"Savitz S.I.","year":"2014","unstructured":"Savitz S.I.; Cramer S.C.; Wechsler L.; Aronowski J.; Boltze J.; Borlongan C.; Case C.; Chase T.; Chopp M.; Carmichael S.T.; Cramer S.C.; Duncan P.; Finklestein S.; Fischkoff S.; Guzman R.; Hess D.C.; Huang D.; Hinson J.; Kautz S.; Kondziolka D.; Mays R.; Misra V.; Mitsias P.; Modo M.; Muir K.; Savitz S.I.; Sinden J.; Snyder E.; Steinberg G.; Vahidy F.; Wechsler L.; Willing A.; Wolf S.; Yankee E.; Yavagal D.R.; Stem cells as an emerging paradigm in stroke 3: Enhancing the development of clinical trials. Stroke  2014,45(2),634-639","journal-title":"Stroke"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jnnp-2019-322515","volume":"91","author":"Muir K.W.","year":"2020","unstructured":"Muir K.W.; Bulters D.; Willmot M.; Sprigg N.; Dixit A.; Ward N.; Tyrrell P.; Majid A.; Dunn L.; Bath P.; Howell J.; Stroemer P.; Pollock K.; Sinden J.; Intracerebral implantation of human neural stem cells and motor recovery after stroke: Multicentre prospective single-arm study (PISCES-2). J Neurol Neurosurg Psychiatry  2020,91(4),396-401","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=86","first-page":"1","author":"Steinberg G.K.","year":"2018","unstructured":"Steinberg G.K.; Kondziolka D.; Wechsler L.R.; Lunsford L.D.; Kim A.S.; Johnson J.N.; Bates D.; Poggio G.; Case C.; McGrogan M.; Yankee E.W.; Schwartz N.E.; Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): A phase 1\/2a study. J Neurosurg  2018,1-11","journal-title":"J Neurosurg"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12883-017-0955-6","volume":"17","author":"Shichinohe H.","year":"2017","unstructured":"Shichinohe H.; Kawabori M.; Iijima H.; Teramoto T.; Abumiya T.; Nakayama N.; Kazumata K.; Terasaka S.; Arato T.; Houkin K.; Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke. BMC Neurol  2017,17(1),179","journal-title":"BMC Neurol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nbd.2012.03.002","volume":"46","author":"Wei L.","year":"2012","unstructured":"Wei L.; Fraser J.L.; Lu Z.Y.; Hu X.; Yu S.P.; Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis  2012,46(3),635-645","journal-title":"Neurobiol Dis"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1161\/STROKEAHA.112.656900","volume":"43","author":"Sakata H.","year":"2012","unstructured":"Sakata H.; Niizuma K.; Wakai T.; Narasimhan P.; Maier C.M.; Chan P.H.; Neural stem cells genetically modified to overexpress cu\/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. Stroke  2012,43(9),2423-2429","journal-title":"Stroke"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/stem.1098","volume":"30","author":"Doeppner T.R.","year":"2012","unstructured":"Doeppner T.R.; Ewert T.A.S.; T\u00f6nges L.; Herz J.; Zechariah A.; ElAli A.; Ludwig A.K.; Giebel B.; Nagel F.; Dietz G.P.H.; Weise J.; Hermann D.M.; B\u00e4hr M.; Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation. Stem Cells  2012,30(6),1297-1310","journal-title":"Stem Cells"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1474-4422(22)00526-9","volume":"22","author":"Moniche F.","year":"2023","unstructured":"Moniche F.; Cabezas-Rodriguez J.A.; Valverde R.; Escudero-Martinez I.; Lebrato-Hernandez L.; Pardo-Galiana B.; Ainz L.; Medina-Rodriguez M.; de la Torre J.; Escamilla-Gomez V.; Ortega-Quintanilla J.; Zapata-Arriaza E.; de Alb\u00f3niga-Chindurza A.; Mancha F.; Gamero M.A.; Perez S.; Espinosa-Rosso R.; Forero-Diaz L.; Moya M.; Pi\u00f1ero P.; Calder\u00f3n-Cabrera C.; Nogueras S.; Jimenez R.; Martin V.; Delgado F.; Ochoa-Sep\u00falveda J.J.; Quijano B.; Mata R.; Santos-Gonz\u00e1lez M.; Carmona-Sanchez G.; Herrera C.; Gonzalez A.; Montaner J.; Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial. Lancet Neurol  2023,22(2),137-146","journal-title":"Lancet Neurol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"535","DOI":"10.23736\/S0390-5616.18.04532-0","volume":"62","author":"Iaccarino C.","year":"2018","unstructured":"Iaccarino C.; Carretta A.; Nicolosi F.; Morselli C.; Epidemiology of severe traumatic brain injury. J Neurosurg Sci  2018,62(5),535-541","journal-title":"J Neurosurg Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/0963689717714102","volume":"26","author":"Galgano M.","year":"2017","unstructured":"Galgano M.; Toshkezi G.; Qiu X.; Russell T.; Chin L.; Zhao L.R.; Traumatic brain injury. Cell Transplant  2017,26(7),1118-1130","journal-title":"Cell Transplant"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","volume":"66","author":"Gardner R.C.","year":"2015","unstructured":"Gardner R.C.; Yaffe K.; Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci,  2015,66(Pt B),75-80","journal-title":"Mol Cell Neurosci,"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1089\/neu.2013.3080","volume":"31","author":"Glushakova O.Y.","year":"2014","unstructured":"Glushakova O.Y.; Johnson D.; Hayes R.L.; Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma  2014,31(13),1180-1193","journal-title":"J Neurotrauma"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3727\/096368911X586783","volume":"21","author":"Boltze J.","year":"2012","unstructured":"Boltze J.; Reich D.M.; Hau S.; Reymann K.G.; Strassburger M.; Lobsien D.; Wagner D.C.; Kamprad M.; Stahl T.; Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant  2012,21(4),723-737","journal-title":"Cell Transplant"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-018-0812-z","volume":"18","author":"Weston N.M.","year":"2018","unstructured":"Weston N.M.; Sun D.; The Potential of stem cells in treatment of traumatic brain injury. Curr Neurol Neurosci Rep  2018,18(1),1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=98","first-page":"145","volume":"58","author":"Dela Pe\u00f1a I.","year":"2014","unstructured":"Dela Pe\u00f1a I.; Sanberg P.R.; Acosta S.; Tajiri N.; Lin S.Z.; Borlongan C.V.; Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor. J Neurosurg Sci  2014,58(3),145-149","journal-title":"J Neurosurg Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/14737175.2016.1184086","volume":"16","author":"Nguyen H.","year":"2016","unstructured":"Nguyen H.; Aum D.; Mashkouri S.; Rao G.; Vega Gonzales-Portillo J.D.; Reyes S.; Borlongan C.V.; Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases. Expert Rev Neurother  2016,16(8),915-926","journal-title":"Expert Rev Neurother"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/neu.2008.0818","volume":"27","author":"Kim H.J.","year":"2010","unstructured":"Kim H.J.; Lee J.H.; Kim S.H.; Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J Neurotrauma  2010,27(1),131-138","journal-title":"J Neurotrauma"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/j.1582-4934.2009.00987.x","volume":"15","author":"Lanfranconi S.","year":"2009","unstructured":"Lanfranconi S.; Locatelli F.; Corti S.; Candelise L.; Comi G.P.; Baron P.L.; Strazzer S.; Bresolin N.; Bersano A.; Growth factors in ischemic stroke. J Cell Mol Med  2009,15(8),1645-1687","journal-title":"J Cell Mol Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"e1202","DOI":"10.1212\/WNL.0000000000011450","volume":"96","author":"Kawabori M.","year":"2021","unstructured":"Kawabori M.; Weintraub A.H.; Imai H.; Zinkevych I.; McAllister P.; Steinberg G.K.; Frishberg B.M.; Yasuhara T.; Chen J.W.; Cramer S.C.; Achrol A.S.; Schwartz N.E.; Suenaga J.; Lu D.C.; Semeniv I.; Nakamura H.; Kondziolka D.; Chida D.; Kaneko T.; Karasawa Y.; Paadre S.; Nejadnik B.; Bates D.; Stonehouse A.H.; Richardson R.M.; Okonkwo D.O.; Cell Therapy for Chronic TBI. Neurology  2021,96(8),e1202-e1214","journal-title":"Neurology"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.biocel.2014.08.003","volume":"56","author":"Merson T.D.","year":"2014","unstructured":"Merson T.D.; Bourne J.A.; Endogenous neurogenesis following ischaemic brain injury: Insights for therapeutic strategies. Int J Biochem Cell Biol  2014,56,4-19","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=104","first-page":"173","volume":"61","author":"Liska M.G.","year":"2017","unstructured":"Liska M.G.; Crowley M.G.; Nguyen H.; Borlongan C.V.; Biobridge concept in stem cell therapy for ischemic stroke. J Neurosurg Sci  2017,61(2),173-179","journal-title":"J Neurosurg Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.4103\/1673-5374.335833","volume":"17","author":"Badner A.","year":"2022","unstructured":"Badner A.; Cummings B.; The endogenous progenitor response following traumatic brain injury: a target for cell therapy paradigms. Neural Regen Res  2022,17(11),2351-2354","journal-title":"Neural Regen Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e74857","DOI":"10.1371\/journal.pone.0074857","volume":"8","author":"Tajiri N.","year":"2013","unstructured":"Tajiri N.; Kaneko Y.; Shinozuka K.; Ishikawa H.; Yankee E.; McGrogan M.; Case C.; Borlongan C.V.; Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One  2013,8(9),e74857","journal-title":"PLoS One"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5736059","volume":"2016","author":"Luarte A.","year":"2016","unstructured":"Luarte A.; B\u00e1tiz L.F.; Wyneken U.; Lafourcade C.; Potential therapies by stem cell-derived exosomes in CNS diseases: Focusing on the neurogenic niche. Stem Cells Int  2016,2016,1-16","journal-title":"Stem Cells Int"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuint.2016.08.003","volume":"111","author":"Zhang Y.","year":"2017","unstructured":"Zhang Y.; Chopp M.; Zhang Z.G.; Katakowski M.; Xin H.; Qu C.; Ali M.; Mahmood A.; Xiong Y.; Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int  2017,111,69-81","journal-title":"Neurochem Int"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/CS20120226","volume":"124","author":"Chang C.P.","year":"2013","unstructured":"Chang C.P.; Chio C.C.; Cheong C.U.; Chao C.M.; Cheng B.C.; Lin M.T.; Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.  Clin Sci  (Lond)  2013,124(3),165-176","journal-title":"Clin Sci  (Lond)"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/jnc.14859","volume":"153","author":"Liu X.Y.","year":"2020","unstructured":"Liu X.Y.; Wei M.G.; Liang J.; Xu H.H.; Wang J.J.; Wang J.; Yang X.P.; Lv F.F.; Wang K.Q.; Duan J.H.; Tu Y.; Zhang S.; Chen C.; Li X.H.; Injury\u2010preconditioning secretome of umbilical cord mesenchymal stem cells amplified the neurogenesis and cognitive recovery after severe traumatic brain injury in rats. J Neurochem  2020,153(2),230-251","journal-title":"J Neurochem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1089\/neu.2021.0045","volume":"38","author":"Badner A.","year":"2021","unstructured":"Badner A.; Reinhardt E.K.; Nguyen T.V.; Midani N.; Marshall A.T.; Lepe C.A.; Echeverria K.; Lepe J.J.; Torrecampo V.; Bertan S.H.; Tran S.H.; Anderson A.J.; Cummings B.J.; Freshly thawed cryobanked human neural stem cells engraft within endogenous neurogenic niches and restore cognitive function after chronic traumatic brain injury. J Neurotrauma  2021,38(19),2731-2746","journal-title":"J Neurotrauma"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1080\/03007995.2022.2141482","volume":"38","author":"Kawabori M.","year":"2022","unstructured":"Kawabori M.; Chida D.; Nejadnik B.; Stonehouse A.H.; Okonkwo D.O.; Cell therapies for acute and chronic traumatic brain injury. Curr Med Res Opin  2022,38(12),2183-2189","journal-title":"Curr Med Res Opin"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13619-020-00043-7","volume":"9","author":"Sharma A.K.","year":"2020","unstructured":"Sharma A.K.; Sane H.M.; Kulkarni P.P.; Gokulchandran N.; Biju H.; Badhe P.B.; Autologous bone marrow mononuclear cell transplantation in patients with chronic traumatic brain injury- a clinical study. Cell Regen  2020,9(1),3","journal-title":"Cell Regen"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666240509092903","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/229761\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666240509092903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T09:00:58Z","timestamp":1733562058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/229761\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":113,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x22666240509092903","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}